BDBM267455 2-(5-tert-Butyl-4-chloro-2-methyl-2H-pyrazol-3-yl)-7-morpholin-4-yl- 5-(2-trifluoromethyl-phenyl)-1H-imidazo[4,5-b]pyridine hydrochloride::US9718820, Compound 61A

SMILES Cn1nc(c(Cl)c1-c1nc2c(cc(nc2[nH]1)-c1ccccc1C(F)(F)F)N1CCOCC1)C(C)(C)C

InChI Key InChIKey=SUGJDLJBMBGZEA-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 267455   

TargetTransient receptor potential M8 protein(Canis lupus familiaris (Dog))
Janssen Pharmaceutica

US Patent
LigandPNGBDBM267455(2-(5-tert-Butyl-4-chloro-2-methyl-2H-pyrazol-3-yl)...)
Affinity DataIC50:  5.30nMT: 2°CAssay Description:HEK293 cells stably expressing canine TRPM8 were routinely grown as monolayers in Dulbecco's minimum essential medium supplemented with 10% FBS, ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent